The bio side of tech.

March 4, 2018 0 Comments

Vijay Pande led a16z’s investment in health-tech company BioAge, and uses this post to explain the rationale. They have the ambitious goal of identifying biomarkers for aging in youthful blood. Vijay makes it easy for non-scientists to understand the meaning and implications. | learn more